13287_2021_2165_MOESM4_ESM.docx (21.75 kB)
Download fileAdditional file 4 of Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series
journal contribution
posted on 2021-01-30, 04:30 authored by Seyed-Mohammad Reza Hashemian, Rasoul Aliannejad, Morteza Zarrabi, Masoud Soleimani, Massoud Vosough, Seyedeh-Esmat Hosseini, Hamed Hossieni, Saeid Heidari Keshel, Zeinab Naderpour, Ensiyeh Hajizadeh-Saffar, Elham Shajareh, Hamidreza Jamaati, Mina Soufi-Zomorrod, Naghmeh Khavandgar, Hediyeh Alemi, Aliasghar Karimi, Neda Pak, Negin Hossieni Rouzbahani, Masoumeh Nouri, Majid Sorouri, Ladan Kashani, Hoda Madani, Nasser Aghdami, Mohammad Vasei, Hossein BaharvandAdditional file 4: Table S2. Laboratory findings before the first and after the last cell infusions.
Funding
Tehran University of Medical Sciences Iranian Council of Stem Cell Research and Technology Barkat Pharmaceutical Group Pharmed Royesh Venture Capital Fund
History
References
- 10.1001/jama.2020.1585
- 10.1056/NEJMoa2001017
- 10.1016/S0140-6736(20)30183-5
- 10.1016/S0140-6736(20)30211-7
- 10.1016/S0140-6736(20)30566-3
- 10.1016/j.ijantimicag.2020.106208
- 10.1007/s00109-020-01927-6
- 10.1007/s13238-020-00738-2
- 10.1016/j.stem.2012.05.015
- 10.1038/srep39889
- 10.1016/j.cellimm.2017.08.009
- 10.3390/cells8080784
- 10.1155/2013/130763
- 10.1016/j.stem.2009.05.003
- 10.1161/CIRCRESAHA.118.313251
- 10.1183/13993003.00858-2020
- 10.1016/j.eclinm.2020.100454
- 10.14336/AD.2020.0228
- 10.1038/s41598-018-23396-1
- 10.1016/j.jcyt.2018.11.003
- 10.1002/sctm.17-0282
- 10.1016/S2213-2600(14)70291-7
- 10.1016/S2213-2600(18)30418-1
- 10.1186/1465-9921-15-39
- 10.3389/fimmu.2019.01191
- 10.1016/S2213-2600(14)70217-6
- 10.1002/jcb.27642
- 10.1073/pnas.0907996106
- 10.1146/annurev-physiol-020518-114320
- 10.5966/sctm.2016-0289
- 10.1016/j.cell.2016.01.043
- 10.1089/scd.2020.0080
- 10.1111/jth.14768
